Vol 3 Issue 1

CELL AND GENE THERAPY INSIGHTS

January 2017 Issue

Vol 3 Issue 1

Download PDF

Featuring

Issue Spotlight: Translation and Application of Gene Editing
Other articles

SPOTLIGHT

Translation and Application of Gene Editing
George Church
Guest Editor:
George Church, Professor, Genetics at Harvard Medical School

Editorial

<em>In vivo</em> genome editing as a therapeutic strategy for treatment of inherited retinal dystrophies: how close are we to realization?

In vivo genome editing as a therapeutic strategy for treatment of inherited retinal dystrophies: how close are we to realization?

Knut Stieger
8 February 2017
Read
Advances & challenges of using CRISPR-Cas9 gene editing for treating Duchenne muscular dystrophy

Advances & challenges of using CRISPR-Cas9 gene editing for treating Duchenne muscular dystrophy

D L Ouellet, B Duchêne, J Iyombe-Engembe et al.
8 February 2017
Read

Expert Insight

Repurposing CRISPR-Cas systems as DNA-based smart antimicrobials

Repurposing CRISPR-Cas systems as DNA-based smart antimicrobials

Rodolphe Barrangou, David G Ousterout
26 April 2017
Read
Current gene editing strategies for the mucopolysaccharidoses

Current gene editing strategies for the mucopolysaccharidoses

M Osborn, D Hyun Yoon, B Hee Lee et al.
8 February 2017
Read
Recent advances in the use of ZFN-mediated gene editing for human gene therapy

Recent advances in the use of ZFN-mediated gene editing for human gene therapy

Srinivasan Chandrasegaran
8 February 2017
Read

Interview

Gene editing of peripheral blood T cells for cancer immunotherapy

Gene editing of peripheral blood T cells for cancer immunotherapy

Avery Posey
8 February 2017
Read

Journal articles

Commercial Insights

Cell & Gene Therapy Commercial Insight – June 2017

Cell & Gene Therapy Commercial Insight – June 2017

17 July 2017
Read
Cell & Gene Therapy Commercial Insight – January 2017

Cell & Gene Therapy Commercial Insight – January 2017

8 February 2017
Read